Page 98 - MI-1-1

Microbes & Immunity Dynamics between phage, bacteria, and mammalian cells

Author contributions doi: 10.1128/aac.01630-05

Conceptualization: Wei Yan, Sharon S.Y. Leung 8. Tsonos J, Oosterik LH, Tuntufye HN, et al. A cocktail
Investigation: Wei Yan, Pengfei Zhang of in vitro efficient phages is not a guarantee for in vivo
Methodology: Wei Yan, Pengfei Zhang therapeutic results against avian colibacillosis. Vet Microbiol.
2014;171(3-4):470-479.
Writing – original draft: Wei Yan, Sharon S.Y. Leung
Writing – review & editing: Pengfei Zhang, Kenneth K.W. doi: 10.1016/j.vetmic.2013.10.021
To, Sharon S.Y. Leung 9. Ngassam-Tchamba C, Duprez JN, Fergestad M, et al.
In vitro and in vivo assessment of phage therapy against
Ethics approval and consent to participate Staphylococcus aureus causing bovine mastitis. J Glob
Not applicable. Antimicrob Resist. 2020;22:762-770.
doi: 10.1016/j.jgar.2020.06.020
Consent for publication
10. Ribet D, Cossart P. How bacterial pathogens colonize
Not applicable. their hosts and invade deeper tissues. Microbes Infect.
2015;17(3):173-183.
Availability of data doi: 10.1016/j.micinf.2015.01.004
Data are available from the corresponding author upon 11. Mekalanos JJ. Environmental signals controlling expression
reasonable request. of virulence determinants in bacteria. J Bacteriol.
1992;174(1):1-7.
References
doi: 10.1128/jb.174.1.1-7.1992
1. Moelling K, Broecker F, Willy C. A wake-up call: We need
phage therapy now. Viruses. 2018;10(12):688. 12. Hesse S, Rajaure M, Wall E, et al. Phage resistance in
multidrug-resistant Klebsiella pneumoniae ST258 evolves via
doi: 10.3390/v10120688 diverse mutations that culminate in impaired adsorption.
2. Jasim HN, Hafidh RR, Abdulamir AS. Formation of mBio. 2020;11(1):e02530-19.
therapeutic phage cocktail and endolysin to highly multi- doi: 10.1128/mBio.02530-19
drug resistant Acinetobacter baumannii: In vitro and in vivo
study. Iran J Basic Med Sci. 2018;21(11):1100-1108. 13. Gembara K, Dąbrowska K. Phage-specific antibodies. Curr
Opin Biotechnol. 2021;68:186-192.
doi: 10.22038/ijbms.2018.27307.6665
doi: 10.1016/j.copbio.2020.11.011
3. Chang RYK, Wallin M, Lin Y, et al. Phage therapy for
respiratory infections. Adv Drug Deliv Rev. 2018;133:76-86. 14. Cowdery JS, Chace JH, Yi AK, Krieg AM. Bacterial DNA
induces NK cells to produce IFN-gamma in vivo and
doi: 10.1016/j.addr.2018.08.001 increases the toxicity of lipopolysaccharides. J Immunol.
4. Liu D, Van Belleghem JD, de Vries CR, et al. The safety and 1996;156(12):4570-4575.
toxicity of phage therapy: A review of animal and clinical 15. Gudmundsson GH, Agerberth B. Neutrophil antibacterial
studies. Viruses. 2021;13(7):1268. peptides, multifunctional effector molecules in the
doi: 10.3390/v13071268 mammalian immune system. J Immunol Methods.
1999;232(1-2):45-54.
5. Wroe JA, Johnson CT, García AJ. Bacteriophage delivering
hydrogels reduce biofilm formation in vitro and infection in doi: 10.1016/s0022-1759(99)00152-0
vivo. J Biomed Mater Res A. 2020;108(1):39-49. 16. Thakur A, Mikkelsen H, Jungersen G. Intracellular
doi: 10.1002/jbm.a.36790 pathogens: Host immunity and microbial persistence
strategies. J Immunol Res. 2019;2019:1356540.
6. Chang RYK, Chen K, Wang J, et al. Proof-of-principle study
in a murine lung infection model of antipseudomonal doi: 10.1155/2019/1356540
activity of phage PEV20 in a dry-powder formulation. 17. Barr JJ, Auro R, Furlan M, et al. Bacteriophage adhering
Antimicrob Agents Chemother. 2018;62(2):e01714-17. to mucus provide a non-host-derived immunity. Proc Natl
Acad Sci U S A. 2013;110(26):10771-10776.
doi: 10.1128/aac.01714-17
doi: 10.1073/pnas.1305923110
7. Gill JJ, Pacan JC, Carson ME, Leslie KE, Griffiths MW,
Sabour PM. Efficacy and pharmacokinetics of bacteriophage 18. Barr JJ, Auro R, Sam-Soon N, et al. Subdiffusive motion
therapy in treatment of subclinical Staphylococcus aureus of bacteriophage in mucosal surfaces increases the
mastitis in lactating dairy cattle. Antimicrob Agents frequency of bacterial encounters. Proc Natl Acad Sci U S A.
Chemother. 2006;50(9):2912-2918. 2015;112(44):13675-13680.

Volume 1 Issue 1 (2024) 92 doi: 10.36922/mi.3141